Anti-CD19 Monoclonal Antibody (16C2)

Subcat	Description	Isotype	Conjugate	Price	Availability
ASPC609	Anti-CD19 Antibody (16C2)	Human IgG1	None	$460	In stock	Add
ASPC609-P	Anti-CD19 Antibody (16C2), PE	Human IgG1	PE	$1,180	2-3 weeks	Add
ASPC609-A	Anti-CD19 Antibody (16C2), APC	Human IgG1	APC	$980	2-3 weeks	Add
ASPC609-H	Anti-CD19 Antibody (16C2), HRP	Human IgG1	HRP	$600	2-3 weeks	Add
ASPC609-B	Anti-CD19 Antibody (16C2), Biotin	Human IgG1	Biotin	$680	2-3 weeks	Add

Anti-CD19 Monoclonal Antibody (16C2)
- Product Description:
  
  The Anti-CD19 antibody is a human monoclonal antibody recommended for use in ELISA, western blot, flow cytometry, Radioimmunoassay and other applications. This antibody specifically targets CD19 and demonstrates reactivity with human.
  
  Applications:
  
  Enzyme-Linked Immunosorbent Assay, Western Blot, Flow Cytometry, Radioimmunoassay
  
  Target:
  
  CD19
  
  Target Species:
  
  Human
  
  Specificity:
  
  This antibody reacts with human CD19.
  
  Clonality:
  
  Monoclonal
  
  Clone ID:
  
  16C2
  
  Purification:
  
  The antibody was purified by affinity chromatography.
  
  Purity:
  
  >95% as determined by SDS-PAGE
  
  Aggregation:
  
  <5% as determined by SEC
  
  Form:
  
  Liquid
  
  Endotoxin:
  
  Please contact us for more information.
  
  Formulation:
  
  Contact us for custom product formulation.
  
  Preservative:
  
  BSA and Azide free.
  
  Stabilizer:
  
  None
  
  Shipping:
  
  Shipped at 4°C.
  
  Storage:
  
  This antibody can be store at 2°C-8°C for one month. Upon delivery aliquot. For longer storage, store at -20°C. Avoid repeated freeze-thaw cycles.
Anti-CD19 Monoclonal Antibody (16C2) Applications
- Note:
  
  Optimal dilutions/concentrations should be determined by the end user.

Gene Symbol

CD19

Protein Name

B-lymphocyte antigen CD19

Introduction

This gene encodes a member of the immunoglobulin gene superfamily. Expression of this cell surface protein is restricted to B cell lymphocytes. This protein is a reliable marker for pre-B cells but its expression diminishes during terminal B cell differentiation in antibody secreting plasma cells. The protein has two N-terminal extracellular Ig-like domains separated by a non-Ig-like domain, a hydrophobic transmembrane domain, and a large C-terminal cytoplasmic domain. This protein forms a complex with several membrane proteins including complement receptor type 2 (CD21) and tetraspanin (CD81) and this complex reduces the threshold for antigen-initiated B cell activation. Activation of this B-cell antigen receptor complex activates the phosphatidylinositol 3-kinase signalling pathway and the subsequent release of intracellular stores of calcium ions. This protein is a target of chimeric antigen receptor (CAR) T-cells used in the treatment of lymphoblastic leukemia. Mutations in this gene are associated with the disease common variable immunodeficiency 3 (CVID3) which results in a failure of B-cell differentiation and impaired secretion of immunoglobulins. CVID3 is characterized by hypogammaglobulinemia, an inability to mount an antibody response to antigen, and recurrent bacterial infections.

Alternative Names

CD19 Molecule; B-Lymphocyte Surface Antigen B4; T-Cell Surface Antigen Leu-12; Differentiation Antigen CD19; CD19 Antigen; B-Lymphocyte Antigen CD19; CVID3; B4

Gene ID

930

UniProt

P15391

Molecule Mass

CD Molecules

Related Disease

Immunodeficiency, common variable, 3 (CVID3)

Subcellular Location

Cell membrane

Cell Line Specificity

Group enriched

Function

Functions as a coreceptor for the B-cell antigen receptor complex (BCR) on B-lymphocytes.

Customer Reviews

There are no reviews for Product Name.

Submit a review and receive an Amazon gift card.

Publications

There are no publications for Product Name.

If you couldn't find the specific publication, you can:
Submit a Citation Get a Publication Reward